Replimune Group (NASDAQ:REPL) Rating Reiterated by Piper Sandler

Piper Sandler restated their overweight rating on shares of Replimune Group (NASDAQ:REPL – Get Rating) in a research note published on Monday morning, Benzinga reports. The firm currently has a $44.00 target price on the stock. A number of other brokerages have also commented on REPL. HC Wainwright boosted their price objective on Replimune Group […]

Related Keywords

Hong Kong ,Piper Sandler ,Ef Hutton Acquisition Co ,News Ratings For Replimune Group Daily ,Replimune Group ,Life Insurance Co ,Replimune Group Company Profile ,Replimune Group Stock Down ,Replimune Group Inc ,Allspring Global Investments Holdings ,Hong Kong Ltd ,Hedge Funds Weigh In On Replimune Group ,Analyst Recommendations For Replimune Group ,Get Rating ,Group Stock Down ,Kong Ltd ,Global Investments Holdings ,Quantbot Technologies ,Replimune Group Daily ,Nasdaq Repl ,Trepl ,Medical ,Reiterated Rating ,